Having built a big operation during the pandemic it could stick or twist but either way investors will soon want a decision
What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses, will keep signing partnerships and will try to ignore churlishness in Brussels.
The long term, though, is another matter. Being big in vaccines was never part of chief executive Pascal Soriot’s grand plan for AstraZeneca, so there’s a decision to be made about what to do with an operation that has been built almost by accident during a global emergency.
